Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Toxicokinetics.

A P van Birgelen1, M van den Berg

  • 1National Institute of Environmental Health Sciences, Environmental Toxicology Program, Research Triangle Park, NC 27709, USA.

Food Additives and Contaminants
|July 27, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Suboptimal quality of female oncofertility care is associated with lowered quality of life.

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation·2026
Same author

[Diagnostics and treatment of suicidality; a matter of customization].

Tijdschrift voor psychiatrie·2024
Same author

Hospital-related costs of sepsis around the world: A systematic review exploring the economic burden of sepsis.

Journal of critical care·2022
Same author

Protocol for a randomized controlled multicenter trial assessing the efficacy of leuprorelin for severe polycystic liver disease: the AGAINST-PLD study.

BMC gastroenterology·2022
Same author

Tamoxifen for the treatment of polycystic liver disease: A case report.

Medicine·2021
Same author

Screening for aneurysms of the abdominal aorta using a simple screening device.

The ultrasound journal·2020

Dioxin toxicokinetics depend on lipophilicity, metabolism, and liver CYP1A2 binding. Humans and rodents show similar sensitivities, but humans require lower daily intake due to pharmacokinetic differences.

Area of Science:

  • Environmental Toxicology
  • Pharmacokinetics
  • Biochemistry

Background:

  • Dioxin toxicokinetics are influenced by lipophilicity, metabolism, and liver CYP1A2 binding.
  • CYP1A2 induction, controlled by the aryl hydrocarbon receptor (AhR), affects dioxin sequestration and distribution.
  • Lipophilicity, increasing with chlorination, governs absorption and tissue partitioning.

Purpose of the Study:

  • To elucidate the toxicokinetic determinants of dioxin and related compounds.
  • To compare human and rodent sensitivities to dioxin-like compounds.
  • To highlight the need for physiologically based pharmacokinetic models for human risk assessment.

Main Methods:

  • Analysis of toxicokinetic properties including lipophilicity, metabolism, and CYP1A2 binding.

Related Experiment Videos

  • Evaluation of CYP1A2 induction and its role in hepatic sequestration.
  • Comparative analysis of human and rodent sensitivity using various toxicokinetic endpoints.

    • Main Results:

    • Metabolism is the rate-limiting step for dioxin elimination.
    • CYP1A2 induction leads to hepatic sequestration and non-linear dose-dependent tissue distribution.
    • Humans and rodents exhibit similar sensitivities, but humans require lower daily intake due to pharmacokinetic variations.

    Conclusions:

    • Physiologically based pharmacokinetic models are essential for accurately estimating human daily intake of dioxin-like compounds.
    • Understanding toxicokinetic differences is crucial for effective risk assessment and management.
    • Hepatic sequestration and altered tissue distribution impact overall dioxin body burden.